PRIME-XV solutions for T cell cultures offer serum-free, xeno-free, chemically defined and animal component-free media solutions to fulfill the potential of T cell applications from research to the clinic. Manufactured to provide an optimal environment during ex-vivo manipulations, PRIME-XV T cell media products have been formulated to deliver improved performance over serum-containing media while maintaining functionality and potency.
The PRIME-XV family of products is designed to simplify the transition to clinical production while adhering to global and regional regulatory standards. Irvine Scientific understands that adherence to a stringent Quality Management System including a robust Raw Material Program are critical to ensure traceability, consistency and reliable performance in supporting immunotherapy applications.
To facilitate clinical applications and scale-up, both PRIME-XV T Cell Expansion XSFM and PRIME-XV T Cell CDM are available for custom formulation and packaging.